New Weight-Loss drug shows promise in early trial

NCT ID NCT07431086

Recruiting now Disease control Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Feb 27, 2026 · Last updated May 13, 2026 · Updated 15 times

Summary

This study tests a new drug called olatorepatide in 120 adults who are overweight or obese but do not have diabetes. The drug aims to help with weight loss by targeting hormones that control appetite. Researchers will check how safe the drug is, how the body processes it, and how much weight participants lose compared to those taking a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERWEIGHT OR OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clinical Site Partners, LLC DBA Flourish Research
RECRUITING

Winter Park, Florida, 32789, United States
Diablo Clinical Research - Flourish Research
RECRUITING

Walnut Creek, California, 94598, United States
Flourish Research - San Antonio Medical Trials
RECRUITING

San Antonio, Texas, 78229, United States

Conditions

Explore the condition pages connected to this study.

OVERWEIGHT OR OBESITY